These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 28754267

  • 1. Efficient production and optimization of E7 oncoprotein from Iranian human papillomavirus type 16 in Lactococcus lactis using nisin-controlled gene expression (NICE) system.
    Mohseni AH, Razavilar V, Keyvani H, Razavi MR, Khavari-Nejad RA.
    Microb Pathog; 2017 Sep; 110():554-560. PubMed ID: 28754267
    [Abstract] [Full Text] [Related]

  • 2. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis.
    Mohseni AH, Taghinezhad-S S, Keyvani H, Razavilar V.
    BMC Biotechnol; 2019 Jan 24; 19(1):8. PubMed ID: 30678667
    [Abstract] [Full Text] [Related]

  • 3. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
    Mohseni AH, Razavilar V, Keyvani H, Razavi MR, Khavari-Nejad RA.
    J Med Virol; 2019 Feb 24; 91(2):296-307. PubMed ID: 30192395
    [Abstract] [Full Text] [Related]

  • 4. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
    Taghinezhad-S S, Mohseni AH, Keyvani H, Razavilar V.
    Microb Pathog; 2019 Jan 24; 126():149-156. PubMed ID: 30391536
    [Abstract] [Full Text] [Related]

  • 5. Secreted expression of Leuconostoc mesenteroides glucansucrase in Lactococcus lactis for the production of insoluble glucans.
    Skory CD, Côté GL.
    Appl Microbiol Biotechnol; 2015 Dec 24; 99(23):10001-10. PubMed ID: 26239071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimization of nisin production by Lactococcus lactis UQ2 using supplemented whey as alternative culture medium.
    González-Toledo SY, Domínguez-Domínguez J, García-Almendárez BE, Prado-Barragán LA, Regalado-González C.
    J Food Sci; 2010 Aug 01; 75(6):M347-53. PubMed ID: 20722935
    [Abstract] [Full Text] [Related]

  • 9. Variable volume fed-batch fermentation for nisin production by Lactococcus lactis subsp. lactis W28.
    Wu Z, Wang L, Jing Y, Li X, Zhao Y.
    Appl Biochem Biotechnol; 2009 Mar 01; 152(3):372-82. PubMed ID: 18712289
    [Abstract] [Full Text] [Related]

  • 10. Codon Usage Optimization and Construction of Plasmid Encoding Iranian Human Papillomavirus Type 16 E7 Oncogene for Lactococcus Lactis Subsp. Cremoris MG1363.
    Mohseni AH, Razavilar V, Keyvani H, Razavi MR, Khavari Nejad RA.
    Asian Pac J Cancer Prev; 2017 Mar 01; 18(3):783-788. PubMed ID: 28441787
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Production of nisin with continuous adsorption to Amberlite XAD-4 resin using Lactococcus lactis N8 and L. lactis LAC48.
    Tolonen M, Saris PE, Siika-Aho M.
    Appl Microbiol Biotechnol; 2004 Feb 01; 63(6):659-65. PubMed ID: 12910326
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.